Schizophenia – An Ayurvedic Review and Treatment – A Case study

Year : 2024 | Volume :11 | Issue : 01 | Page : 40-48

Khushbu R. Prajapati

Bhaveshkumar B. Paramar

Anandkumar M. Patel

Ram Shukla

Haresh Vyas

Harsh J. Patel

  1. Assistant Professor and Consultant Department of Panchkarma,Saradar Ayurved College and Hospital, Mehsana Gujrat India
  2. Medical officer Department of Panchkarma,Saradar Ayurved College and Hospital, Mehsana Gujrat India
  3. Assistant Professor and Consultant Department of Kaumarbhrity, Saradar Ayurved College and Hospital, Mehsana Gujrat India
  4. Vaidhya Panchakarma Goverment Ayurved Hospital, Kherva, Mehsana Gujarat India
  5. Ayurved Practitioner AyurvedaChikitsa Mandir and Panchakarma Research Center, Ahmedabad Gujarat India
  6. Medical officer Department of Shalyatantra, Saradar Ayurved College and hospital, Mehsana Gujarat India


Schizophrenia is a complex, heterogeneous disorder. It is neuro developmental disorder characterized by problems with thinking (cognition),behavior- not focused on goals, negative symptoms, suicidal thoughts This means having a reduced or impaired ability to function normally and having noemotions(notmakingeyecontact,notchangingfacialexpressions,orspeakinginamonotone).Additionally, the person may lose interest in daily activities, withdraw from relationships, or be unable to sustain and reflection often associated with hearing or speech disorders, extreme confusion and associated functional impairments. The pathophysiology is not known. It is a disease or collection of diseases associated with changes inbrain circuits. This can manifest itself in many ways, from childlike stupidityto a lack of anxiety. pleasure. The type and severity of symptoms may change over time with periods of recovery andabstinence. Some symptoms may occur. Symptoms of schizophrenia in men usually begin in their early tomid-20s. In women, symptoms usually begin in their 20s. It is rare for children to be diagnosed withschizophrenia, these cases are usually more severe and are rare in people over 45 years of age. Schizophrenia affects approximately 24 million people or 1 in 300 people (0.32%) worldwide. This rate is 1 in 222 people (0.45%) among adults. It is not as common as many other mental disorders. Onset is most often during late adolescence and the twenties, and onset tends to happen earlier among men than among women.
Schizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other important areas of life.
Antipsychotics, antidepressants, lithium, and cognitive behavioral therapy are at best effective in reducing symptoms. Post-diagnosis treatment now focuses on reducing psychological symptoms. A 38-year-old female patient came to opd-3 at Panchakarma department, sardar ayurvedic college and hospital with chief complain in gofsmrutinasha, Aspasta-Asambandha case pravriti, Balakavata. Sabdauchharanaevamvyavahara, Atichintita, Manoavasad, Atikrodha,ParasparaSamvada kale Asamarthata, Manobhavavihinamukha, Karmanekastata ,Shirahashoola, Vibandha ,Bhrama since last12years. Shaman chikitsa, Shodhana Chikitsa-Shirodhara, Nasya was performed on the patients.

Keywords: Schizophrenia, Manasroga, Ayurveda, Panchakarma,

[This article belongs to Research & Reviews : A Journal of Ayurvedic Science, Yoga & Naturopathy(rrjoasyn)]

How to cite this article: Khushbu R. Prajapati, Bhaveshkumar B. Paramar, Anandkumar M. Patel, Ram Shukla, Haresh Vyas, Harsh J. Patel. Schizophenia – An Ayurvedic Review and Treatment – A Case study. Research & Reviews : A Journal of Ayurvedic Science, Yoga & Naturopathy. 2024; 11(01):40-48.
How to cite this URL: Khushbu R. Prajapati, Bhaveshkumar B. Paramar, Anandkumar M. Patel, Ram Shukla, Haresh Vyas, Harsh J. Patel. Schizophenia – An Ayurvedic Review and Treatment – A Case study. Research & Reviews : A Journal of Ayurvedic Science, Yoga & Naturopathy. 2024; 11(01):40-48. Available from:


  1. Harrison G, Hopper KI, Craig T, Laska E, Siegel C, Wanderling JO, Dube KC, Ganev K, Giel R, Der Heiden WA, Holmberg SK. Recovery from psychotic illness: a 15-and 25-year international follow-up study. The British journal of psychiatry. 2001 Jun;178(6):506-17.
  2. Osmond H, Smythies J. Schizophrenia: a new approach. Journal of Mental Science. 1952 Apr;98(411):309-15.
  3. Firdaus Z, Singh TD. An insight in pathophysiological mechanism of Alzheimer’s disease and its management using plant natural products. Mini Reviews in Medicinal Chemistry. 2021 Jan 1;21(1):35-57.
  4. Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F, McGee MF, Keefe RS, McEvoy JP, Hsiao JK. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. American Journal of Psychiatry. 2007 Mar;164(3):428-36.
  5. HistoryofSchizophreniaasaPsychiatricDisorder.In:MueserKT,JesteDV,editors. Clinical Handbook of Schizophrenia. New York,New York: Guilford Press; 2008.pp.3–12
  6. Crismon L, Argo TR, Buckley PF. Schizophrenia. In: DiPiro JT, Talbert RL, Yee GC, et al.,editors. 1Pharmacotherapy:APathophysiologicApproach. NewYork,NewYork:McGraw-Hill;2014.pp.1019–1046.
  7. McDonald C,    Murphy      The   new   genetics    of   schizophrenia. PsychiatrClin   NorthAm.2003;26(1):41–63.
  8. Stough C, Lloyd J, Clarke J, Downey L, Hutchison C, Rodgers T, Nathan P. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology. 2001 Aug;156:481-4.
  9. Jalwal P, Singh B, Dahiya J, Khokhara S. A comprehensive review on shankhpushpi a morning glory. The Pharma Innovation. 2016;5(1, Part A):14.
  10. JalwalP,SinghB,DahiyaJ,KhokharaS.Acomprehensivereviewonshankhpushpiamorningglory.ThePharmaInnovationJournal2016;5(1):14-18.
  11. Ahmad I, Zaiba-Beg AZ, Mehmood Z. Antimicrobial potency of selected medicinal plants with special interest in activity against phytopathogenic fungi. Indian Vet med J. 1999;23:299-306.
  12. Shukla PK, Khanna VK, Ali MM, Maurya RR, Handa SS, Srimal RC. Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytotherapy research. 2002 May;16(3):256-60.
  13. Derle Deelip, V., and N. Gujar Kishor. “Anti-inflammatory, analgesic and anti-pyretic activity of Acorus Calamus and Curcuma Amada.” INDIAN DRUGS-BOMBAY-8 (2001): 444-444.
  14. Patel DV, Chandola HM, Baghel MS, Joshi JR. Evaluation of the role of Manasika Bhava in the etiopathogenesis of Madhumeha (NIDDM) and its management by Poly Herbal Antidiabetic Formulation with and without Medhya Rasayana(Doctoral dissertation, Ph. D. Thesis, IPGT & RA, Gujarat Ayurved University, Jamnagar).
  15. Varde AB, Ainapure SS, Naik SR, Amladi SR. Anti-inflammatory activity of coconut oil extract of Acorus calamus, Ocimum sanctum and Ocimumbasilicum in rats. Indian Drugs. 1988;25(6):226-8.
  16. Tortora, Gerard J.., Derrickson, Bryan H.. Principles of Anatomy and Physiology. United Kingdom: Wiley, 2008.

Regular Issue Subscription Case Report
Volume 11
Issue 01
Received October 10, 2023
Accepted April 18, 2024
Published April 23, 2024